scispace - formally typeset
R

Robert Gerlai

Researcher at University of Toronto

Publications -  283
Citations -  19180

Robert Gerlai is an academic researcher from University of Toronto. The author has contributed to research in topics: Zebrafish & Dopaminergic. The author has an hindex of 66, co-authored 269 publications receiving 17016 citations. Previous affiliations of Robert Gerlai include Eli Lilly and Company & University of Hawaii at Manoa.

Papers
More filters
Journal ArticleDOI

Gene-targeting studies of mammalian behavior : is it the mutation or the background genotype ?

TL;DR: The present article will demonstrate that the phenotypical abnormalities attributed to the null mutation in several molecular neurobiological studies could simply result from the effects of background genes.
Journal ArticleDOI

Zebrafish as an emerging model for studying complex brain disorders.

TL;DR: It is argued that zebrafish models of complex brain disorders and drug-induced conditions are a rapidly emerging critical field in translational neuroscience and pharmacology research.
Journal ArticleDOI

Drinks like a fish: zebra fish (Danio rerio) as a behavior genetic model to study alcohol effects

TL;DR: Basic behavioral tests to investigate the acute effects of alcohol on zebra fish and the strategy for generating and screening mutants will be useful for the genetic and biological analysis of acute and chronic drug effects as well as addiction.
Journal ArticleDOI

Mice Lacking Metabotropic Glutamate Receptor 5 Show Impaired Learning and Reduced CA1 Long-Term Potentiation (LTP) But Normal CA3 LTP

TL;DR: Long-term potentiation (LTP) in mGluR5 mutants was significantly reduced in the NMDA receptor (NMDAR)-dependent pathways such as the CA1 region and dentate gyrus of the hippocampus, whereas LTP remained intact in the mossy fiber synapses on the CA3 region, an NMDAR-independent pathway.